Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes

Purpose: Biallelic pathogenic variants in PYGM (glycogen myophosphorylase) cause glycogen storage disease V (GSDV), a skeletal muscle disorder with reported association with hereditary macular dystrophy (HMD). This study investigated the role of PYGM in HMD and broader retinal disease through clinical and functional analyses. Methods: An autosomal recessive HMD family underwent phenotyping and genome sequencing. Separately, data from 65 patients with GSDV (mean age = 51.7 years) were analyzed for retinal involvement. Immunohistochemistry, RT-qPCR and translating ribosome affinity purification assays assessed retinal expression of glycogen phosphorylase (GP) isoenzymes. Glycogenolysis was studied in retinal pigment epithelial (RPE-1) cells. Retinal sections from PygmR50*/R50* mice were also examined. Results: Genome sequencing identified a homozygous pathogenic stop-gain variant in PYGM (NM_005609.4:c.148C > T; p.[Arg50*]) in the proband and affected sibling, and re-phenotyping revealed features of GSDV. Retinal involvement was identified in 30 of 65 GSDV cases (23 bilateral), with higher prevalence in participants >60 years (approximately 2.6-fold) and men (approximately 2-fold). PYGM expression was localized to Müller glia and photoreceptors. Cell-type-specific GP isoenzyme expression was found in mouse retina and RPE-1 cells. RPE-1 cells demonstrated glycogenolysis. PygmR50*/R50* mice lacked glycogen accumulation but exhibited photoreceptor outer segment thinning consistent with Pygm being the predominant isoform expressed in mouse photoreceptors. Conclusions: GSDV is moderately associated with retinopathy, and may present as non-syndromic HMD, warranting retinal monitoring for patients, and the inclusion of PYGM in retinal dystrophy gene panels. Redundancy in retinal glycogenolysis may account for lower penetrance and higher age-related prevalence in patients. Photoreceptor thinning observed in PygmR50*/R50* mice strengthens the association between HMD and GSDV in humans.

Authors

Institutions

Publication Details

Journal
Investigative Ophthalmology & Visual Science
Published
2026-09-11
DOI
https://doi.org/10.1167/iovs.67.11.18
Primary Topic
Glycogen Storage Diseases and Myoclonus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes

Tomàs Pinós, Aditi Mohla, Rowaida Hussein, Chiara Pizzamiglio et al.
Investigative Ophthalmology & Visual Science
Glycogen Storage Diseases and Myoclonus
article

Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes

Tomàs Pinós, Aditi Mohla, Rowaida Hussein, Chiara Pizzamiglio, Siying Lin, H. Robson MacDonald, Regan Klatt, Ammaji Rajala, Maanik Mehta, Katelyn MacNeill, Raju V. S. Rajala, M. Tarnopolsky, Anthony G. Robson, Michel Michaelides, Ajoy Vincent, Kashif Ahmed, A. R. Webster, Elena R. Schiff, Chantal Morel, Graeme Nimmo, Neal Sondheimer, Pearse A. Keane, Philippe P. Monnier, Deepika Parameswarappa, Rosaline Quinlivan, Anupreet Tumber, Erika Tavares, Omar A. Mahroo, Nicola Dowd, Evgueni Ivakine, Alaa Tayyib, Cynthia VandenHoven, Elise Héon, Kamron Khan, Berge A. Minassian
article en

Abstract

Purpose: Biallelic pathogenic variants in PYGM (glycogen myophosphorylase) cause glycogen storage disease V (GSDV), a skeletal muscle disorder with reported association with hereditary macular dystrophy (HMD). This study investigated the role of PYGM in HMD and broader retinal disease through clinical and functional analyses. Methods: An autosomal recessive HMD family underwent phenotyping and genome sequencing. Separately, data from 65 patients with GSDV (mean age = 51.7 years) were analyzed for retinal involvement. Immunohistochemistry, RT-qPCR and translating ribosome affinity purification assays assessed retinal expression of glycogen phosphorylase (GP) isoenzymes. Glycogenolysis was studied in retinal pigment epithelial (RPE-1) cells. Retinal sections from PygmR50*/R50* mice were also examined. Results: Genome sequencing identified a homozygous pathogenic stop-gain variant in PYGM (NM_005609.4:c.148C > T; p.[Arg50*]) in the proband and affected sibling, and re-phenotyping revealed features of GSDV. Retinal involvement was identified in 30 of 65 GSDV cases (23 bilateral), with higher prevalence in participants >60 years (approximately 2.6-fold) and men (approximately 2-fold). PYGM expression was localized to Müller glia and photoreceptors. Cell-type-specific GP isoenzyme expression was found in mouse retina and RPE-1 cells. RPE-1 cells demonstrated glycogenolysis. PygmR50*/R50* mice lacked glycogen accumulation but exhibited photoreceptor outer segment thinning consistent with Pygm being the predominant isoform expressed in mouse photoreceptors. Conclusions: GSDV is moderately associated with retinopathy, and may present as non-syndromic HMD, warranting retinal monitoring for patients, and the inclusion of PYGM in retinal dystrophy gene panels. Redundancy in retinal glycogenolysis may account for lower penetrance and higher age-related prevalence in patients. Photoreceptor thinning observed in PygmR50*/R50* mice strengthens the association between HMD and GSDV in humans.

Investigative Ophthalmology & Visual ScienceVol. 67(11)
Tufts University (US), Universitat Autònoma de Barcelona (ES), University of Leeds (GB), St Thomas' Hospital (GB), Moorfields Eye Hospital NHS Foundation Trust (GB), University Health Network (CA), King's College London (GB), University of Toronto (CA), Toronto Western Hospital (CA), Hospital for Sick Children (CA), McMaster Children's Hospital (CA), University of Manchester (GB), National Institute for Health and Care Research (GB), Manchester University NHS Foundation Trust (GB), Vall d'Hebron Institut de Recerca (ES), St Mary's Hospital (GB), Centre for Biomedical Network Research on Rare Diseases (ES), Krembil Foundation (CA), SickKids Foundation (CA), Moorfields Eye Hospital (GB), Genomics (United Kingdom) (GB), Krembil Research Institute, University College London (GB), University of Oklahoma Health Sciences Center (US), The University of Texas Southwestern Medical Center (US)
Zero hunger
Openalex Percentile: Top 10%
Glycogen Storage Diseases and Myoclonus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.